West Pharmaceutical Services (NYSE:WST) has experienced a 31% loss in the past year, triggered by a downward shift in guidance. Multiple class-action lawsuits have been filed, with legal firms Levi & Korsinsky and The Gross Law Firm notifying investors of pending suits and encouraging those who experienced losses exceeding $100K to assert their rights. Financial firm Faruqi & Faruqi, LLP suggests investors have the opportunity to lead the securities fraud lawsuit against WST. Changes in WST's organizational structure along with financial results for Q4 and full-year 2024 have been declared. Bessemer Group Inc and Robeco Institutional Asset Management B.V. have increased their holdings in the company. Moreover, WST announced a significant partnership with Corning targeting pharmaceutical injectable drug delivery.
West Pharmaceutical Services WST News Analytics from Tue, 25 Jan 2022 08:00:00 GMT to Sat, 05 Jul 2025 01:21:50 GMT -
Rating -8
- Innovation -4
- Information 0
- Rumor -4
